Biomedical Engineering Reference
In-Depth Information
[71] Pauletti GM, Gangwar S, Knipp GT, Nerurkar MM, Okumu FW, Tamura K, et al. Structural
requirements for intestinal absorption of peptide drugs. J Control Release 1996;41:3-17.
[72] Kararli TT. Gastrointestinal absorption of drugs. Crit Rev Ther Drug Carrier Syst
1989;6:39-86.
[73] Siegel IA. Permeability of the rat oral mucosa to organic solutes measured in vivo. Arch
Oral Biol 1984;29:13-16.
[74] McMartin C, Hutchinson LE, Hyde R, Peters GE. Analysis of structural requirements
for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci
1987;76:535-40.
[75] Maitani Y, Machida Y, Nagai. T. Influence of molecular weight and charge on nasal
absorption of dextran and DEAE-dextran in rabbits. Int J Pharm 1989;49:23-7.
[76] Donovan MD, Flynn GL, Amidon GL. Absorption of polyethylene glycols 600 through
2000: the molecular weight dependence of gastrointestinal and nasal absorption. Pharm
Res 1990;7:863-8.
[77] Tavakoli-Saberi MR, Audus KL. Cultured buccal epithelium: an in vitro model derived
from the hamster pouch for studying drug transport and metabolism. Pharm Res
1989;6:160-6.
[78] Siegel IA, Izutsu KT, Watson E. Mechanisms of nonelectrolyte penetration across dog
and rabbit oral mucosa in vitro . Arch Oral Biol 1981;26:357-61.
[79] Sandow J, Ditzinger G, Rachs S, Merkle HP. Cyclopeptides as a novel class of transmu-
cosal absorption enhancers. Proc Int Symp Control Release Bioact Mater 1990;17:11-12.
[80] Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri P. Factors and strategies for improv-
ing buccal absorption of peptides. Eur J Pharm Biopharm 2001;51:93-109.
[81] Merkle HP, Wolany G. Buccal delivery for peptide drugs. J Control Release
1992;21:155-64.
[82] Nightingale CH, Greene DS, Quintiliani R. Pharmacokinetics and clinical use of cepha-
losporin antibiotics. J Pharm Sci 1975;64:1899-927.
[83] McNally EJ, Park JY. Peptides and proteins: oral absorption. In: Swarbrick J, editor.
Encyclopedia of pharmaceutical technology. 3rd ed., vol. 1. New York, NY: Informa
Healthcare USA; 2007. p. 2713-30.
[84] Okada H, Yamazaki I, Ogawa Y, Hirai S, Yashiki T, Mima H. Vaginal absorption of a
potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by
various routes and absorption enhancement. J Pharm Sci 1982;71:1367-71.
[85] Crane CW, Luntz GR. Absorption of insulin from the human small intestine. Diabetes
1968;17:625-7.
[86] Heyman M, Ducroc R, Desjeux JF, Morgat JL. Horseradish peroxidase trans-
port across adult rabbit jejunum in vitro . Am J Physiol Gastrointest Liver Physiol
1982;242:G558-64.
[87] Kimm MH, Curtis GH, Hardin JA, Gall DG. Transport of bovine serum albumin across
rat jejunum: role of enteric nervous system. Am J Physiol Gastrointest Liver Physiol
1994;266:G186-93.
[88] Green PG, Hinz RS, Kim A, Szoka Jr FC, Guy RH. Iontophoretic delivery of a series of
tripeptides across the skin in vitro . Pharm Res 1991;8:1121-7.
[89] Delie F, Letourneux Y, Nisato D, Puisieux F, Couvreur P. Oral administration of peptides:
study of a glycerolipidic prodrug. Int J Pharm 1995;115:45-52.
[90] Burnham NL. Polymers for delivering peptides and proteins. Am J Hosp Pharm
1994;51:210-8.
[91] Palm K, Luthman K, Ungell AL, Strandlund G, Artursson P. Correlation of drug absorp-
tion with molecular surface properties. J Pharm Sci 1996;85:32-9.
Search WWH ::




Custom Search